We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Use of Cone Beam Kilovoltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00358007
Recruitment Status : Terminated (Administratively Terminated by PI)
First Posted : July 28, 2006
Results First Posted : August 21, 2014
Last Update Posted : November 29, 2016
Information provided by (Responsible Party):

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment;   Masking: None (Open Label);   Primary Purpose: Supportive Care
Condition: Head and Neck Neoplasms
Intervention: Device: PTV Reduction

  Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
Cone Beam CT Undergo a cone beam CT scan

Participant Flow:   Overall Study
    Cone Beam CT

  Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
Cone Beam CT Undergo a cone beam CT scan

Baseline Measures
   Cone Beam CT 
Overall Participants Analyzed 
[Units: Participants]
[Units: Years]
Mean (Standard Deviation)
 58.19  (12.21) 
[Units: Participants]
<=18 years   0 
Between 18 and 65 years   21 
>=65 years   9 
[Units: Participants]
Female   9 
Male   21 
Race (NIH/OMB) 
[Units: Participants]
American Indian or Alaska Native   0 
Asian   1 
Native Hawaiian or Other Pacific Islander   0 
Black or African American   4 
White   25 
More than one race   0 
Unknown or Not Reported   0 
Ethnicity (NIH/OMB) 
[Units: Participants]
Hispanic or Latino   0 
Not Hispanic or Latino   28 
Unknown or Not Reported   2 
Region of Enrollment 
[Units: Participants]
United States   30 

  Outcome Measures

1.  Primary:   Average Interfraction Shift of Patients Undergoing Radiotherapy   [ Time Frame: Daily prior to radiation ]

2.  Primary:   Average Residual Error Motion of Patients Undergoing Radiotherapy   [ Time Frame: Daily after each radiotherapy treatment ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.

  More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.

Results Point of Contact:  
Name/Title: Pramila Rani Anne, MD
Organization: Thomas Jefferson University
phone: 215-955-6702
e-mail: Pramila.Anne@jefferson.edu

Publications of Results:

Responsible Party: Thomas Jefferson University ( Sidney Kimmel Cancer Center at Thomas Jefferson University )
ClinicalTrials.gov Identifier: NCT00358007     History of Changes
Other Study ID Numbers: 06U.195
2006-10 ( Other Identifier: CCRRC )
First Submitted: July 27, 2006
First Posted: July 28, 2006
Results First Submitted: June 12, 2014
Results First Posted: August 21, 2014
Last Update Posted: November 29, 2016